Phase I Study to Assess the Safety of APD-791 When Co-administered With Aspirin
Phase of Trial: Phase I
Latest Information Update: 18 Feb 2019
At a glance
- Drugs Temanogrel (Primary) ; Aspirin; Clopidogrel
- Indications Acute coronary syndromes
- Focus Adverse reactions
- Acronyms PR1C; TG1C
- Sponsors Ildong Pharmaceutical
- 31 Aug 2018 Biomarkers information updated
- 29 Jun 2018 Status changed to discontinued.
- 12 May 2014 According to the Arena Pharmaceuticals media release, Ildong Pharmaceutical has initiated dosing in this trial.